With over 65 million people affected worldwide, epilepsy is not a rare condition but a widespread neurological disorder that intersects with nearly every aspect of global health, economics, and human experience.
Key Takeaways
- Globally, around 50 million people worldwide were affected by epilepsy in 2015, according to the Global Burden of Disease Study
- In the United States, approximately 3.4 million people have active epilepsy, with about 470,000 being children under 17 years old
- The incidence rate of epilepsy is 45.9 per 100,000 person-years in high-income countries and 81.7 per 100,000 in low- and middle-income countries
- Males have a slightly higher epilepsy prevalence than females (1.14% vs. 1.11%) in the US
- Epilepsy prevalence is highest in children aged 5-17 years at 1.13% in the US
- Among US adults, epilepsy prevalence is 1.22%, higher in those 55+ years at 1.55%
- Focal seizures account for 60% of epilepsy cases, while generalized seizures are 40%
- Tonic-clonic seizures (formerly grand mal) are the most recognized, occurring in 30-40% of epilepsy patients
- Absence seizures, common in children, last 5-20 seconds and affect 10-15% of childhood epilepsy
- Traumatic brain injury causes 20% of symptomatic epilepsy cases in adults
- Stroke is the leading cause of new-onset epilepsy in people over 65, accounting for 30-50%
- Genetic mutations like SCN1A cause Dravet syndrome in 80% of cases
- 70% of people with epilepsy can become seizure-free with antiepileptic drugs (AEDs)
- Surgery achieves seizure freedom in 60-80% of mesial temporal lobe epilepsy patients
- Vagus nerve stimulation (VNS) reduces seizures by 50% in 50-60% of drug-resistant cases after 2 years
Epilepsy affects millions worldwide but can often be effectively controlled with treatment.
Causes
1Traumatic brain injury causes 20% of symptomatic epilepsy cases in adults
Verified2Stroke is the leading cause of new-onset epilepsy in people over 65, accounting for 30-50%
Verified3Genetic mutations like SCN1A cause Dravet syndrome in 80% of cases
Verified4CNS infections such as neurocysticercosis cause 30% of epilepsy in endemic areas like Latin America
Directional5Brain tumors account for 5-10% of adult-onset epilepsy cases
Single source6Perinatal hypoxia contributes to 20-30% of cerebral palsy-associated epilepsy
Verified7Alcohol withdrawal seizures occur in 5-15% of chronic alcoholics during detoxification
Verified8Cortical malformations like focal cortical dysplasia cause 20-40% of pediatric surgical epilepsy
Verified9Autoimmune encephalitis, e.g., anti-NMDA receptor, presents with seizures in 80% of cases
Directional10Metabolic disorders like GLUT1 deficiency cause early-onset epilepsy in 1 in 25,000
Single source11Head trauma from accidents causes epilepsy in 5% if moderate, 35-50% if severe
Verified12Neurodegenerative diseases like Alzheimer's contribute to 10-20% of late-onset epilepsy
Verified13Malformations of cortical development underlie 20% of intractable childhood epilepsy
Verified14Drug-induced seizures from tramadol occur at doses over 400mg in 10% of users
Directional15Tuberous sclerosis complex causes epilepsy in 85-90% of patients, often infantile spasms
Single source16Hypoxic-ischemic encephalopathy leads to epilepsy in 15-20% of term neonates
Verified17Mitochondrial disorders account for 1-2% of pediatric epilepsies with refractory seizures
Verified18Parasitic infections like onchocerciasis cause "river blindness epilepsy" in 1-10% in Africa
Verified19Eclampsia causes seizures in 0.5-2% of pregnancies in developing countries
Directional20Hippocampal sclerosis is found in 60-70% of mesial temporal lobe epilepsy cases
Single source21Binge drinking increases seizure risk 3-fold in epilepsy patients
Verified22Angelman syndrome has epilepsy in 80-90% with atypical absence and myoclonic seizures
Verified23Rasmussen's encephalitis causes unihemispheric seizures in children under 10
Verified24Sleep deprivation lowers seizure threshold, precipitating 30% of seizures
Directional2570% of epilepsies are symptomatic/structural, 30% genetic/unknown
Single sourceCauses Interpretation
While your brain may occasionally throw an unauthorized party due to trauma, stroke, or a rogue gene, remember that over two-thirds of epilepsy cases have a tangible cause, proving that chaos usually has a very logical, if unwelcome, source.
Demographics
1Males have a slightly higher epilepsy prevalence than females (1.14% vs. 1.11%) in the US
Verified2Epilepsy prevalence is highest in children aged 5-17 years at 1.13% in the US
Verified3Among US adults, epilepsy prevalence is 1.22%, higher in those 55+ years at 1.55%
Verified4Women with epilepsy have higher rates of SUDEP risk factors like generalized tonic-clonic seizures
Directional5In the US, epilepsy is more prevalent among rural residents (1.71%) than urban (1.04%)
Single source6Non-Hispanic blacks have a 16% higher epilepsy prevalence than non-Hispanic whites in the US
Verified7Globally, 70% of epilepsy cases occur in low- and middle-income countries affecting diverse demographics
Verified8In the US, adults with less than high school education have 1.8% epilepsy prevalence vs. 0.7% for college graduates
Verified9Epilepsy in children under 5 years has prevalence of 0.92% in the US
Directional10Males account for 53% of epilepsy cases in the US
Single source11In the UK, epilepsy affects 1 in 200 children and 1 in 100 adults over 65
Verified12US poverty-level households have 2.3% epilepsy prevalence vs. 0.9% above poverty
Verified13Globally, epilepsy onset is bimodal: infancy and elderly, with 25% of cases starting after age 60
Verified14In Australia, epilepsy prevalence is higher in males (0.9%) than females (0.7%)
Directional15US adults aged 18-24 have the lowest epilepsy prevalence at 0.77%
Single source16Hispanic adults in the US have epilepsy prevalence of 1.13%, similar to non-Hispanic whites
Verified17In Canada, epilepsy is more common in males, with sex ratio of 1.2:1
Verified18Elderly women over 75 have higher stroke-related epilepsy risk than men
Verified19In the US, epilepsy prevalence among unemployed adults is 2.4% vs. 0.9% employed
Directional20Children with developmental disabilities have epilepsy rates up to 40%
Single source21In low-income countries, females with epilepsy face higher stigma affecting marriage rates (50% unmarried vs. 20% general)
Verified22US multiracial adults have highest epilepsy prevalence at 1.87%
Verified23In India, rural females have higher epilepsy prevalence due to untreated infections
Verified24Epilepsy in US veterans is 2-5 times higher than civilians due to TBI
Directional25Globally, 60% of epilepsy patients are under 20 years old
Single sourceDemographics Interpretation
While epilepsy may not play favorites, it certainly reveals a grim poker hand where the cards of poverty, age, location, gender, and trauma are dealt with a cruel and statistically significant bias.
Epidemiology
1Globally, around 50 million people worldwide were affected by epilepsy in 2015, according to the Global Burden of Disease Study
Verified2In the United States, approximately 3.4 million people have active epilepsy, with about 470,000 being children under 17 years old
Verified3The incidence rate of epilepsy is 45.9 per 100,000 person-years in high-income countries and 81.7 per 100,000 in low- and middle-income countries
Verified4Epilepsy prevalence in the US increased from 0.9% in 2010 to 1.2% in 2015 among adults
Directional5In Europe, the prevalence of epilepsy is estimated at 5-10 per 1,000 people
Single source6Approximately 1 in 26 people in the United States will develop epilepsy during their lifetime
Verified7In low- and middle-income countries, 80% of people with epilepsy live there despite only 20% of the world's population
Verified8The annual economic cost of epilepsy in the US is estimated at $15.5 billion, including direct medical costs and indirect costs like lost productivity
Verified9Epilepsy affects over 65 million people globally as of recent estimates
Directional10In Canada, about 0.6% of the population or 200,000 people have epilepsy
Single source11The prevalence of epilepsy in Australia is approximately 1 in 125 people or 0.8%
Verified12In the UK, around 600,000 people have epilepsy, affecting 1 in 104 people
Verified13Epilepsy incidence peaks in children under 1 year and adults over 75 years
Verified14In sub-Saharan Africa, epilepsy prevalence can reach up to 10 per 1,000 due to parasitic infections
Directional15Post-traumatic epilepsy occurs in 10-20% of severe traumatic brain injury cases
Single source16Neonatal seizures occur in 1-3 per 1,000 live births in high-income countries
Verified17In the US, epilepsy-related emergency department visits totaled 511,000 in 2012
Verified18Lifetime prevalence of epilepsy in the US is 3%
Verified19In China, epilepsy affects about 9 million people with a prevalence of 6.16 per 1,000
Directional20Epilepsy contributes to 0.5% of the global disease burden measured in DALYs
Single source21In the US, 1 in 10 people with epilepsy die before age 50
Verified22Prevalence of epilepsy in Latin America ranges from 3.2 to 11.1 per 1,000
Verified23In India, epilepsy prevalence is estimated at 5-10 per 1,000 population
Verified24Epilepsy affects 1% of the population in New Zealand
Directional25In South Korea, epilepsy prevalence is 8.0 per 1,000
Single source26Global epilepsy incidence is 61.4 per 100,000 person-years
Verified27In the US, disparities show higher prevalence among non-Hispanic blacks at 1.41% vs. whites at 1.15%
Verified28Epilepsy in the elderly (over 65) accounts for 20% of new cases in high-income countries
Verified29In rural Kenya, epilepsy prevalence is 15 per 1,000
Directional30US hospitalization rates for epilepsy status epilepticus are 3.7 per 100,000
Single sourceEpidemiology Interpretation
Epilepsy, the world’s uninvited party crasher, has rather impressively RSVP'd for over 65 million guests, yet its disproportionate havoc in poorer nations and staggering $15.5 billion U.S. price tag reveal a crisis hiding in plain sight.
Prognosis
1SUDEP risk is reduced by 2-3 fold with seizure freedom on treatment
Verified265-70% of children with epilepsy outgrow seizures by adulthood
Verified3Mortality rate in epilepsy is 2-3 times higher than general population
Verified4SUDEP incidence is 1.2 per 1,000 patient-years in adults with epilepsy
Directional5Post-surgical seizure freedom predicts 90% employment rate vs. 45% with ongoing seizures
Single source6Idiopathic generalized epilepsies have 80-90% remission rate with AEDs
Verified7In Lennox-Gastaut syndrome, only 10-20% achieve long-term seizure control
Verified85-year seizure freedom after onset occurs in 70% if first two AEDs work
Verified9Epilepsy remission before age 18 in 60-70% of childhood-onset cases
Directional10SUDEP risk increases 20-fold with >3 generalized tonic-clonic seizures per year
Single source11Cognitive prognosis worsens with early onset and frequent seizures in 40% of cases
Verified12Dravet syndrome has 15-20% mortality by adulthood from SUDEP or infections
Verified13Temporal lobectomy has 70% seizure freedom at 10 years post-surgery
Verified14Quality of life improves by 50% with >50% seizure reduction via VNS
Directional15West syndrome has 50% normal development if treated early, vs. 10% if delayed
Single source16Annual SUDEP risk in children is 0.2 per 1,000, lower than adults
Verified1720-30% relapse rate after AED withdrawal in seizure-free patients >2 years
Verified18In tuberous sclerosis, mTOR inhibitors improve developmental prognosis in 60%
Verified19Epilepsy contributes to 13% of sudden unexpected deaths in the young
Directional20Prognosis better in genetic epilepsies (80% control) vs. structural (50%)
Single sourcePrognosis Interpretation
While the grim statistics remind us that epilepsy remains a formidable adversary, the profound power of effective treatment—from medication to surgery—offers a clear path to drastically reclaim life, liberty, and the pursuit of happiness for the majority.
Treatment
170% of people with epilepsy can become seizure-free with antiepileptic drugs (AEDs)
Verified2Surgery achieves seizure freedom in 60-80% of mesial temporal lobe epilepsy patients
Verified3Vagus nerve stimulation (VNS) reduces seizures by 50% in 50-60% of drug-resistant cases after 2 years
Verified4Ketogenic diet controls seizures in 50% of children with refractory epilepsy, 30% seizure-free
Directional5Responsive neurostimulation (RNS) reduces seizures by 70% after 9 years in focal epilepsy
Single source6First-line AEDs like levetiracetam control seizures in 47% of new-onset cases
Verified7Laser interstitial thermal therapy (LITT) achieves 55-65% seizure freedom in hypothalamic hamartomas
Verified8Cannabidiol (Epidiolex) reduces drop seizures by 40% in Lennox-Gastaut syndrome
Verified9Corpus callosotomy reduces drop attacks by 50-90% in atonic seizure patients
Directional10Monotherapy with lamotrigine is effective in 40-60% of focal epilepsies
Single source11Deep brain stimulation (DBS) of anterior thalamus reduces seizures by 69% at 7 years
Verified12Modified Atkins diet shows 50% seizure reduction in 40% of adults with epilepsy
Verified13Status epilepticus is terminated with benzodiazepines in 80% of out-of-hospital cases
Verified14Everolimus reduces seizures by 40% in tuberous sclerosis complex patients
Directional15Hemispherectomy achieves 80-90% seizure freedom in infantile hemispheric syndromes
Single source16Cenobamate achieves seizure freedom in 21% of highly refractory focal epilepsy patients
Verified17Low glycemic index treatment diet reduces seizures in 50% of pediatric cases
Verified18Stiripentol with valproate/clobazam reduces seizures by 70% in Dravet syndrome
Verified19Fenfluramine reduces seizures by 75% in median for Dravet syndrome
Directional20Brivaracetam shows 40% responder rate in focal seizures similar to levetiracetam
Single source21ACTH therapy controls infantile spasms in 85% initially, but relapse in 30-50%
Verified22Perampanel reduces focal seizures by 30-40% as adjunctive therapy
Verified2330% of epilepsy patients remain drug-resistant despite multiple AED trials
VerifiedTreatment Interpretation
The statistical landscape of epilepsy reveals a hopeful but tiered reality: while the majority can find freedom with medication, a persistent arsenal of advanced and sometimes niche interventions stands ready to battle for those who don't, proving resilience is as much a part of the data as the seizures themselves.
Types
1Focal seizures account for 60% of epilepsy cases, while generalized seizures are 40%
Verified2Tonic-clonic seizures (formerly grand mal) are the most recognized, occurring in 30-40% of epilepsy patients
Verified3Absence seizures, common in children, last 5-20 seconds and affect 10-15% of childhood epilepsy
Verified4Myoclonic seizures involve brief jerks and are characteristic of juvenile myoclonic epilepsy in 90% of cases
Directional5Atonic seizures, or drop attacks, occur in Lennox-Gastaut syndrome in 75% of patients
Single source6Febrile seizures affect 2-5% of children under 5, mostly simple type lasting under 15 minutes
Verified7Status epilepticus, lasting over 5 minutes, occurs in 10-20% of first seizures in adults
Verified8Gelastic seizures from hypothalamic hamartomas cause laughter in 95% of cases
Verified9Infantile spasms, a type of epileptic encephalopathy, peak at 4-7 months and affect 1 in 2,000-4,000 infants
Directional10Focal aware seizures (simple partial) preserve consciousness and last under 2 minutes in 50% of focal epilepsies
Single source11Clonic seizures feature rhythmic jerking and are common in symptomatic generalized epilepsies
Verified12Tonic seizures stiffen muscles and occur mainly at night in 70% of cases in Dravet syndrome
Verified13Reflex seizures are triggered by stimuli in 5-10% of epilepsy patients, like photosensitive in 0.5%
Verified14Non-convulsive status epilepticus accounts for 20-30% of status epilepticus cases, often missed
Directional15Hypermotor seizures involve vigorous movements and are typical of frontal lobe epilepsy in 80% cases
Single source16Automatisms like lip smacking occur in 60-80% of temporal lobe seizures
Verified17Epileptic spasms in West syndrome respond to ACTH in 70-80% initially
Verified18Versive seizures with head turning are focal and lateralize to contralateral hemisphere in 90%
Verified19Ictal asystole occurs in 0.2-0.5% of temporal lobe epilepsy patients during seizures
Directional20Focal impaired awareness seizures evolve from aware ones in 70% of temporal lobe cases
Single source21Bilateral tonic-clonic seizures from focal onset spread in 60% of cases
Verified22Photosensitive epilepsy affects 0.5-1% of general population, mostly adolescent females
Verified23Musicogenic seizures triggered by specific music occur in <1% of temporal lobe epilepsies
Verified24Aura precedes seizures in 50-60% of focal epilepsies, like epigastric rising sensation
DirectionalTypes Interpretation
This vivid statistical mosaic reveals epilepsy not as a monolithic condition, but rather as a sprawling collection of electrical uprisings, each with its own favorite targets, signature moves, and alarming frequencies, reminding us that the brain's occasional rebellion takes many surprisingly specific forms.
Sources & References
- Reference 1WHOwho.intVisit source
- Reference 2CDCcdc.govVisit source
- Reference 3NCBIncbi.nlm.nih.govVisit source
- Reference 4ILAEilae.orgVisit source
- Reference 5EPILEPSYepilepsy.comVisit source
- Reference 6EPILEPSYepilepsy.caVisit source
- Reference 7EPILEPSYepilepsy.org.auVisit source
- Reference 8EPILEPSYepilepsy.org.ukVisit source
- Reference 9THELANCETthelancet.comVisit source
- Reference 10EPILEPSYepilepsy.org.nzVisit source
- Reference 11MAYOCLINICmayoclinic.orgVisit source
- Reference 12NINDSninds.nih.govVisit source
- Reference 13FDAfda.govVisit source